CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
PAVS
Paranovus Entertainment Technology Ltd.
There isn't enough reported data to score PAVS yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PAVS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
PAVS's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | โ |
| Current | 35x | $31.89 | โ |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
PAVS PE Valuation
PAVS has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
PAVS Forward outlook
There aren't enough analyst estimates for PAVS to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over PAVS in the latest year-over-year earnings comparison.
PAVS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$11,207.63 | +$165,762.33 |
| Q1 2024 | -$176,969.96 | +$2,433,030.04 |
| Q1 2023 | -$2,610,000.00 | +$318,000.00 |
| Q1 2022 | -$2,928,000.00 | -4167% |
| Q1 2021 | $72,000.00 | -94% |
| Q1 2020 | $1,272,000.00 | -35% |
PAVS lost $11,207.63 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over PAVS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
PAVS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $2.2M | +2960% |
| Q3 2025 | $12.4M | +18033% |
| Q1 2025 | $71.5K | -99% |
| Q3 2024 | $68.5K | -99% |
| Q1 2024 | $6.5M | -86% |
| Q3 2023 | $6.3M | -88% |
| Q1 2023 | $45.2M | -50% |
| Q1 2022 | $89.5M | +80% |
PAVS's revenue has slid since its 2022 peak: $2M last quarter, down 67% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -641% | -571 points |
| Q3 2025 | -5.1% | -208 points |
| Q1 2025 | -9482% | -9374 points |
| Q3 2024 | -1690% | -1653 points |
| Q1 2024 | -71% | -5.9 points |
| Q3 2023 | 203% | +207 points |
| Q1 2023 | -108% | -125 points |
| Q3 2022 | -37% | -61 points |
PAVS's operating margin was โ641% last quarter, down 571 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PAVS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2024 | -$11.9M | +$992.5K |
| Q1 2023 | -$12.9M | +$17.7M |
| Q1 2022 | -$30.5M | -$23.2M |
| Q1 2021 | -$7.3M | -176% |
| Q1 2020 | $9.6M | +54% |
PAVS's free cash flow has turned negative after years in the green: โ$64M over the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
PAVS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -14.3x | Net Cash |
| Q1 2020 | -2.0x | Net Cash |
| Q1 2019 | -0.6x | Net Cash |
PAVS has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PAVS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
PAVS's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
PAVS PE vs Consumer Defensive Sector
| Metric | PAVS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | โ |
PAVS has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over PAVS on trend strength, trading above more of its moving averages.
PAVS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.29 | 23% below |
| 20 week MA | $4.46 | 43% below |
| 50 week MA | $750.6 | 100% below |
| 100 week MA | $62,797.4 | 100% below |
| 200 week MA | $173,224.8 | 100% below |
PAVS is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over PAVS on returns for 2026, with the stronger performance.
PAVS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10,032,000.0 | $4,392,000.0 | -56% |
| 2021 | $4,392,000.0 | $1,284,000.0 | -71% |
| 2022 | $1,284,000.0 | $489,600.0 | -62% |
| 2023 | $489,600.0 | $295,200.0 | -40% |
| 2024 | $295,200.0 | $158,400.0 | -46% |
| 2025 | $158,400.0 | $2,604.0 | -98% |
| 2026 YTD | $2,604.0 | $2.54 | -100% |
PAVS has finished every year since 2020 lower, and it's down 100% so far in 2026.